Work

Combination of donafenib and anti-PD-1 antibody plus trans-arterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (uHCC).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e16197

Authors: Shanzhi Gu, Yulin Tan, Huan Zhou, Hongtao Hu, Tongsen Zheng, Zhendong Zheng, Xu Zhu, Mu Yuan

Institutions: Central South University, Hunan Cancer Hospital, First Affiliated Hospital of Bengbu Medical College, Zhengzhou University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, General Hospital of Shenyang Military Region, Peking University Cancer Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281778522

Cites:

Cited by: 6

Related to: 10